New Delhi [India], February 24 (ANI): With two new strains of Covid-19, one each from the UK and Brazil, confirmed in a number of states, AIIMS Director Randeep Guleria on Wednesday said that vaccines will be able to control the spread of coronavirus and lessen the mortality rate.
New Delhi [India], February 17 (ANI): Coronavirus vaccines might be available in the open market by end of the year only when prime targeted people are covered and there is an equivalence of supply and demand, said Dr. Randeep Guleria, Director of All India Institute of Medical Sciences (
New Delhi [India], January 16 (ANI): Urging the people to have faith in India's researchers, scientists, regulatory authorities, All India Institute of Medical Sciences (AIIMS) Director Dr Randeep Singh Guleria on Saturday reassured the nation that Bharat Biotech's COVAXIN vaccine is safe
New Delhi [India], January 16 (ANI): AIIMS Director Dr Randeep Singh Guleria and NITI Aayog member VK Paul on Saturday were administered the COVID-19 vaccine shot at AIIMS Delhi on the inaugural day of nationwide roll-out of vaccination.
New Delhi [India], January 3 (ANI): All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria on Sunday clarified that approval of COVAXIN, Bharat Biotech's COVID-19 vaccine is for an emergency situation and not emergency use authorisation which is given to Serum Institute
New Delhi [India], January 3 (ANI): All India Institute of Medical Sciences (AIIMS) director Dr Randeep Singh Guleria today lauded the work done by Indian laboratories in making indigenous vaccines.
New Delhi [India], January 3 (ANI): As India gears up for the world's largest vaccination programme, the Ministry of Health and Family Welfare addressed apprehensions expressed by the public regarding the COVID-19 vaccine's effectiveness, safety and availability, among others.
New Delhi [India], January 3 (ANI): With vaccine roll out on the cards after Drugs Controller General of India's (DCGI) approval, the country needs to tackle public and administrative challenges to have a smooth vaccination roll-out, said Randeep Guleria, Director, All India Institute of Med
New Delhi [India], January 1 (ANI): BJP president Jagat Prakash Nadda on Friday informed that he and his family members have fully recovered from COVID-19, thanking AIIMS director Randeep Guleria and his team for their dedication and support.
New Delhi [India], December 30 (ANI): Terming the approval for Oxford-AstraZeneca vaccine for use in the UK as a "big step forward", AIIMS Delhi Director Dr Randeep Guleria on Wednesday said that India will have the COVID-19 vaccine within days.
New Delhi [India], December 31 (ANI): The government is aggressively working on the Covid-19 mass vaccination program and there will be no delay in the inoculation process, Dr Randeep Guleria, director All India Institute of Medical Sciences said on Wednesday. He also said that priority grou
New Delhi [India], December 31 (ANI): With India confirming at least 20 cases of the new UK strain of Covid-19, All India Institute of Medical Sciences director Randeep Guleria on Wednesday said that it is a possibility that the new mutation could have been present in the country even in